Send the following on WhatsApp
Continue to ChatEntecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologie, biochemical, and serology outcomes through 96 weeks - https://avesis.istanbul.edu.tr/yayin/cad34360-26d6-4ebf-ba1a-d3d16f436d91/entecavir-therapy-for-lamivudine-refractory-chronic-hepatitis-b-improved-virologie-biochemical-and-serology-outcomes-through-96-weeks